Blue Earth Diagnostics
Quick facts
Marketed products
- Flotufolastat (18F) · Oncology
Flotufolastat (18F) is a fluorine-18 labeled folate analog that binds to folate receptors on cancer cells for positron emission tomography (PET) imaging. - piflufolastat (18F) · Oncology
Piflufolastat (18F) is a fluorine-18 labeled small molecule that binds to prostate-specific membrane antigen (PSMA) for positron emission tomography (PET) imaging of PSMA-expressing tumors.
Phase 3 pipeline
- rhPSMA-7.3 (18F) Injection · Oncology
rhPSMA-7.3 (18F) Injection is a radiopharmaceutical that targets prostate-specific membrane antigen (PSMA) for diagnostic imaging.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: